chr8-81527085-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001105281.6(FABP12):c.283G>A(p.Val95Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,611,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001105281.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FABP12 | NM_001105281.6 | c.283G>A | p.Val95Ile | missense_variant | 4/5 | NP_001098751.1 | ||
FABP12 | XM_006716465.4 | c.283G>A | p.Val95Ile | missense_variant | 4/5 | XP_006716528.1 | ||
FABP12 | XM_011517577.3 | c.283G>A | p.Val95Ile | missense_variant | 5/6 | XP_011515879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FABP12 | ENST00000360464.6 | c.283G>A | p.Val95Ile | missense_variant | 4/5 | 1 | ENSP00000353650.4 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000688 AC: 17AN: 247252Hom.: 0 AF XY: 0.0000821 AC XY: 11AN XY: 134028
GnomAD4 exome AF: 0.000260 AC: 379AN: 1459380Hom.: 0 Cov.: 29 AF XY: 0.000240 AC XY: 174AN XY: 725874
GnomAD4 genome AF: 0.000151 AC: 23AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | The c.283G>A (p.V95I) alteration is located in exon 3 (coding exon 3) of the FABP12 gene. This alteration results from a G to A substitution at nucleotide position 283, causing the valine (V) at amino acid position 95 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at